eviQ Education



eviQ Education eNews

 Rapid Learn + Listen package

Hypersensitivity and anaphylaxis


Some anti-cancer drugs are known for their potential to cause infusion reactions. Allergic infusion reactions, such as hypersensitivity, can lead to anaphylaxis which may present with symptoms including cyanosis and loss of consciousness. Anaphylaxis is considered an oncological emergency and can be life-threatening.

The 5-minute mini-module will help you:

  • recognise the signs and symptoms of infusion reactions, hypersensitivity and anaphylaxis
  • assess the severity of the reaction
  • initiate the right interventions and escalate care appropriately.

Learn more in the new rapid learning →


"Only a handful have been really severe or anaphylactic. And this was one of the more severe reactions that just didn't go quite as expected."
Kirsten Thompson, National Management Consultant, NT Health.

In this Rapid Listening episode, we hear from Kirsten Thompson, National Management Consultant from NT Health, who shares her experience with a patient having a hypersensitivity reaction.

Listen to the case study podcast →

Extravasation: Updated resources + webinar recording

Our extravasation resources have been updated! The clinical content of the course, clinical resources and patient information resources were refreshed to align with new evidence and reflect user feedback.

The eviQ teams hosted a one-hour webinar, which featured expert presenters to describe changes to the course and how to navigate the new resources.

View the new course →

 Watch the webinar recording →

Our year in review

It will likely come as no surprise we are a team who love data! This year our reflections were pleasantly surprising - we were dominated by producing V4 of ADAC but still managed to deliver a full program of new and updated eLearning resources, webinars, workshops and mini-quizzes! 

Our favourite stat is seeing that 143 of you that have participated as members of our clinical advisory committees. This wonderful representation of clinical expertise keeps our resources accurate, appropriate and reflective of the real-world environment and needs of our health professionals. Thank you!

We are always welcoming new members, join the conversation!

Become a reviewer →

We won!

The eviQ Education team are celebrating a clean sweep at LearnX awards last month! We took three from three awards - including the top prize for our CVADs eLearning package in the Health & Safety Training category. The resource also won two Diamond awards for Best eLearning Project (Industry Specific) and Best Learning Model (Blended).

This is the second year in a row the team have celebrated winning entries - and we are very pleased to share the industry recognition with the 30 clinical contributors who supported the development of the resource with their clinical expertise.

COSA + pharmacy workshop

The team debuted their new purple T-shirts at COSA in Brisbane last month! It was a jam-packed program and wonderful to see everyone engaging with the team at the booth.

We also hosted a session at the COSA Cancer Pharmacists Group (CPG) Clinical Development Day and received some fantastic insight and ideas on how to implement the first cancer pharmacy ADAC across Australia, starting with a pilot project next year. 

Would you 'like' us on Facebook?

It's survey time again! Last year you told us you wanted more videos, which led to the production of eight videos to complement our CVAD eLearning package - we can't wait to share them with you early next year.

This year the survey is much shorter (around 5 minutes) and features questions around social media - we're keen to hear if you're interested in keeping up to date with new clinical information, resources and events from the eviQ teams as they become available on the channels you're using (such as Facebook). 

Please take a moment to give us your feedback so we can best support you in 2023!

Complete the planning survey now!

Want a visit?

Our ADAC implementation activities will take us on the road quite a bit next year, and we would love to tie in any in-service visits to facilities. Please complete the planning survey to indicate your interest!

ADAC update

Next year will be the year of ADAC! The wonderful new versions will be released in 2023 - with some exciting enhancements - and we really can not wait to finally share it with you!

Kidney dosing has changed

New guidelines have been released by eviQ that represent a significant change to kidney function assessment and dosing recommendations for 59 anticancer drugs. The Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) guideline is a decision support tool to guide clinical decision and is collaboration with an international, multidisciplinary working party.

View the guideline on eviQ.

Rapid learning

Understand the purpose of the ADDIKD guideline, methods of assessing kidney function in cancer patients, why eGFR (via CKD-EPI) is the preferred method of estimating kidney function, and kidney function categories for dosing and monitoring with this mini-module.

Learn more in the new rapid learning →


Do you know the best method of assessing kidney function in your cancer patients?

Take the mini-quiz on our mobile app to get a quick understanding of the changes and test your knowledge.
Access by downloading the app via the QR code below.


EOI - radiation reviewers wanted

eviQ are currently reviewing and updating their contrast-related clinical resources and procedures along with the related patient information sheet. If you are a radiation oncology health care professional (doctor, nurse, radiation therapist, or other allied health) please register your interest here by COB 22 December 2022.

eviQ updates

eviQ medical oncology – rare cancers

A new rare cancers category has been developed under the medical oncology content area on eviQ. You will find medical oncology treatment protocols for rare cancers here. Protocols in the rare cancers category are also available in their relevant eviQ medical oncology tumour streams categories.

Visit the rare cancers homepage →

eviQ protocol updates

Subscribe to receive content area specific updates direct to your inbox - click here to sign up to eviQ newsletters.

eviQ also lists all recently added protocols and updates made in the past 90 days on their content area homepages: Cancer geneticsHaematology and BMTMedical oncologyRadiation oncologyClinical resources

eviQ →

As usual...

eviQ Education flyers available for your practice - Featuring a catalogue of all our courses. You can now print your own flyer to display in your workplace.

Rapid Learning series - New to Rapid learning? Browse our Rapid Learning library.

Rapid Listening series - Listen to clinical case studies on our website, or listen/subscribe to the podcasts on Spotify or Google Podcasts.

Facilitator training: Register for on-demand facilitator training and/or an online Q & A session webinar:

  • ADAC Q & A session -  Wednesday 9 November 2022 at 2.00 - 3.00 pm (AEST) 

View the training calendar here.

 Want to know what's new? Keep an eye on our website newsfeed.

 Share the love: If you have a colleague who may be interested in receiving this update – please invite them to subscribe! If you have a link you'd like to share, think about tweeting it with hashtag #eviQ .



Q: "Do I get a certificate for the online part of the CVADs course?"

A: The CVAD course is blended learning, and a certificate is only awarded by your facilitator after successfully completing the competency assessments.

Visit the CVAD course page →



Did you know?

Do you know the risk factors for hypersensitivity and anaphylaxis?

Find out in our Hypersensitivity and anaphylaxis Rapid Learning →





Level 4,
1 Reserve Road,
St Leonards
Cammeraygal Country

Contact us  |  Unsubscribe